MiR-7-5p-mediated downregulation of PARP1 impacts DNA homologous recombination repair and resistance to doxorubicin in small cell lung cancer
Abstract Background Chemo-resistance is one of the major challenges in the therapy of small cell lung cancer (SCLC). Multiple mechanisms are thought to be involved in chemo-resistance during SCLC treatment, but unfortunately, these mechanisms have not been well elucidated. Herein, we investigated th...
Main Authors: | Jinzhi Lai, Hainan Yang, Yanyang Zhu, Mei Ruan, Yayu Huang, Qiuyu Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-06-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12885-019-5798-7 |
Similar Items
-
Resistance to PARP-inhibitors in Cancer Therapy
by: Alicia eMontoni, et al.
Published: (2013-02-01) -
Practical considerations for optimising homologous recombination repair mutation testing in patients with metastatic prostate cancer
by: David Gonzalez, et al.
Published: (2021-07-01) -
PARP Inhibitors for Sensitization of Alkylation Chemotherapy in Glioblastoma: Impact of Blood-Brain Barrier and Molecular Heterogeneity
by: Shiv K. Gupta, et al.
Published: (2019-01-01) -
Toward a Quantitative Analysis of PARP-1 and Poly(ADP-ribosyl)ation in Cellular Senescence
by: Edmonds, Yvette M.
Published: (2014) -
Exploring the Frequency of Homologous Recombination DNA Repair Dysfunction in Multiple Cancer Types
by: Lucy Gentles, et al.
Published: (2019-03-01)